Cancel
John van Duzer
Chemistry Manufacturing and Controls
@
Acrivon Therapeutics
3708.152bq@q16k00f.2ky
Sign up to see email
See Linkedin
Known information
- Has over 30 years of experience in medicinal chemistry research, chemical development programs, and GMP manufacturing.
- Inventor of Lumiracoxib, a marketed cyclooxygenase 2 inhibitor.
- Inventor of ricolinostat and citarinostat, which are HDAC6 inhibitors for the treatment of multiple myeloma.
- Held manufacturing and technical operations leadership roles at Collegium Pharmaceutical, Eloxx Pharmaceuticals, Acetylon Pharmaceuticals, Mersana Therapeutics, and ActivBiotics Corporation.
- Served as a consultant to Celgene.
- Received a Ph.D. in Synthetic Organic Chemistry from Yale University.
- Earned a B.A. in Chemistry from the University of Pennsylvania.
- Co-inventor of 36 patents.
- Co-authored 18 peer-reviewed scientific papers.
About Acrivon Therapeutics
Acrivon Therapeutics develops precision oncology medicines using a proprietary proteomics-based platform, with its lead candidate ACR-368 in a Phase 2 trial for multiple tumor types.
Report inaccurate information